|
STAU2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.983900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.612000E-02 |
| Normal-vs-Stage2 |
5.679600E-03 |
| Normal-vs-Stage3 |
1.285980E-02 |
| Normal-vs-Stage4 |
2.024000E-03 |
| Stage1-vs-Stage2 |
3.317000E-01 |
| Stage1-vs-Stage3 |
5.766200E-01 |
| Stage1-vs-Stage4 |
1.471560E-01 |
| Stage2-vs-Stage3 |
5.969400E-01 |
| Stage2-vs-Stage4 |
6.871600E-01 |
| Stage3-vs-Stage4 |
3.349200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.456500E-03 |
| Normal-vs-AfricanAmerican |
7.481600E-01 |
| Normal-vs-Asian |
1.546090E-02 |
| Caucasian-vs-AfricanAmerican |
1.892450E-02 |
| Caucasian-vs-Asian |
7.481800E-01 |
| AfricanAmerican-vs-Asian |
3.774000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.878020E-03 |
| Normal-vs-Female |
1.747750E-02 |
| Male-vs-Female |
1.696800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.030200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.678140E-03 |
| Normal-vs-Age(61-80Yrs) |
1.112180E-02 |
| Normal-vs-Age(81-100Yrs) |
2.781200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.632100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.356000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.699600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.626800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.025800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.322000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.361200E-01 |
| Classical-VS-Follicular |
1.777910E-02 |
| Classical-VS-Other |
4.320000E-01 |
| Classical-VS-Normal |
5.557800E-02 |
| Tall-VS-Follicular |
5.927000E-01 |
| Tall-VS-Other |
7.524800E-01 |
| Tall-VS-Normal |
2.424000E-02 |
| Follicular-VS-Other |
9.860800E-01 |
| Follicular-VS-Normal |
1.564180E-03 |
| Other-VS-Normal |
1.141010E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.009000E-04 |
| Normal-vs-N1 |
3.017900E-02 |
| N0-vs-N1 |
6.057400E-01 |
|
|
